roti dhalpuri
Selected indexed studies
- Acute lymphoblastic leukaemia. (Nat Rev Dis Primers, 2024) [PMID:38871740]
- AI is a viable alternative to high throughput screening: a 318-target study. (Sci Rep, 2024) [PMID:38565852]
- 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. (Blood, 2021) [PMID:33876209]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- AI is a viable alternative to high throughput screening: a 318-target study. (2024) pubmed
- Acute lymphoblastic leukaemia. (2024) pubmed
- 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. (2021) pubmed
- Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. (2021) pubmed
- Author Correction: AI is a viable alternative to high throughput screening: a 318-target study. (2024) pubmed
- Subclinical hypothyroidism. (2007) pubmed
- Iodine and Hyperthyroidism: A Double-Edged Sword. (2025) pubmed
- The Acrobats. (2004) pubmed
- Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. (2025) pubmed
- Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML. (2024) pubmed